Patent · US Expired

3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis

US6531493B1 · kind B1 · utility

6Cited by

0References

10Claims

0Family size

Assignee

ALTANA PHARMA AG · DE

Inventors

Hans-Peter Kley · Allensbach, DE
Karl Sanders · Santa Clara, US

Key dates

Filing date	Sep 5, 2001
Grant date	Mar 11, 2003
Priority date	—
Expiry date	Sep 5, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the novel use of 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide, a pharmacologically tolerable salt thereof or its N-oxide in the treatment of multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.